Focus Partners Wealth’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.4K Buy
+17,443
New +$42.6K ﹤0.01% 2689
2025
Q2
Sell
-13,295
Closed -$57.4K 2108
2025
Q1
$57.4K Buy
13,295
+1,023
+8% +$4.13K ﹤0.01% 1835
2024
Q4
$39.3K Sell
12,272
-94
-0.8% -$315 ﹤0.01% 1825
2024
Q3
$35.4K Buy
+12,366
New +$34.7K ﹤0.01% 1550

Other funds holding ORGO

Focus Partners Wealth's ORGO Position: Q2 2026 in Review

Focus Partners Wealth opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 17,443 shares worth $42.4K. The stake represents ﹤0.01% of the portfolio and ranks #2689 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in ORGO as recently as Q1 2025.

Focus Partners Wealth first reported a position in ORGO in Q3 2024 and has held it in 4 quarters since. The position peaked at $57.4K in Q1 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Focus Partners Wealth held 17,443 shares of Organogenesis Holdings worth $42.4K as of Q2 2026.
  • Organogenesis Holdings was a new Focus Partners Wealth position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2689 holding.
  • Focus Partners Wealth first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 4 quarters since.
  • Focus Partners Wealth's Organogenesis Holdings position peaked at $57.4K in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.